Leading Financial Service Provider in India | Canara Bank Securities Ltd

Alivus Life Sciences Ltd.

Sep 30 BSE 929.35 ( -27.10 -2.83%)

Volume12392

Prev. Close
956.45

Open Price
956.50

Today's Low / High

925.00 956.50

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

827.10 1259.75

Sep 30 NSE 929.15( -23.15 -2.43%)

Volume97779

Prev. Close
952.30

Open Price
947.55

Today's Low / High

924.50 952.00

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

850.00 1251.00

Market Cap. ( ₹ in Cr. )	11398.94	P/BV	4.49	Book Value ( ₹ )	206.92
52 Week High/Low ( ₹ )	1251/850	FV/ML	2/1	P/E(X)	23.47
Book Closure	01/09/2025	EPS ( ₹ )	39.58	Div Yield (%)	0.00

Standalone

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00


INCOME
Revenue From Operations [Net]	2339.84	2184.77	2047.84	2087.45	1861.40
Other Operating Revenues	47.05	98.44	113.38	35.77	23.77
Total Operating Revenues	2386.88	2283.21	2161.22	2123.21	1885.17

Other Income	34.57	12.04	28.96	14.70	0.81
Total Revenue	2421.45	2295.26	2190.18	2137.92	1885.98

EXPENSES
Cost Of Materials Consumed	1053.50	1058.58	1098.53	1001.56	976.20
Operating And Direct Expenses	2.43	3.17	2.48	2.66	1.82
Changes In Inventories Of FG,WIP And Stock-In Trade	27.35	-56.57	-84.44	41.32	-70.70
Employee Benefit Expenses	251.70	258.16	180.18	168.72	149.13
Finance Costs	2.41	1.55	0.55	27.96	87.55
Depreciation And Amortisation Expenses	60.61	53.45	42.09	37.88	33.39
Other Expenses	369.32	345.63	322.18	292.89	237.65
Total Expenses	1767.32	1663.97	1561.57	1572.99	1415.03

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	654.13	631.29	628.61	564.93	470.94

Profit/Loss Before Tax	654.13	631.29	628.61	564.93	470.94

Tax Expenses-Continued Operations
Current Tax	162.44	152.21	150.61	137.63	112.75
Deferred Tax	6.06	8.19	11.04	8.57	6.62
Total Tax Expenses	168.50	160.40	161.65	146.20	119.36
Profit/Loss After Tax And Before ExtraOrdinary Items	485.63	470.89	466.96	418.72	351.58

Profit/Loss From Continuing Operations	485.63	470.89	466.96	418.72	351.58

Profit/Loss For The Period	485.63	470.89	466.96	418.72	351.58

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	39.63	38.43	38.11	35.63	32.61
Diluted EPS (Rs.)	39.53	38.38	38.11	35.63	32.61

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	275.69	385.96	128.65	0.00
Equity Dividend Rate (%)	250.00	1125.00	1050.00	1050.00	0.00

Markets

Income Statement

INCOME STATEMENT

Alivus Life Sciences Ltd.